Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey.
Ünal Ç, Özmen T, Ordu Ç, Pilanci KN, İlgün AS, Gökmen E, Almuradova E, Özdoğan M, Güler N, Uras C, Kara H, Demircan O, Işık S, Alço G, Saip P, Aydın E, Duymaz T, Çelebi F, Yararbaş K, Soybir G, Ozmen V.
Ünal Ç, et al. Among authors: ozdogan m.
Front Oncol. 2023 Jun 28;13:1151733. doi: 10.3389/fonc.2023.1151733. eCollection 2023.
Front Oncol. 2023.
PMID: 37448522
Free PMC article.